Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2020 Mar 13;14(1):77–84. doi: 10.1055/s-0040-1702255

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives License, which permits unrestricted reproduction and distribution, for non-commercial purposes only; and use and reproduction, but not distribution, of adapted material for non-commercial purposes only, provided the original work is properly cited.

PMC Copyright notice

Fig. 2 — ( A ) Fifteen days after implantation, Group C: presence of congested vessels (CV), young fibroblasts (YF), and collagen fibers disposed (CFD) in parallel bundles involving the cavity ( HE, 400×magnification, scale: 25 µm). Area of polyethylene tube (PT) implant. ( B ) Fifteen days after implantation, Group M10: cavity surrounded by moderate inflammatory infiltrate (IIM), CV, presence of ovoid and fusiform YF, and multinucleated giant cells (MGC) (HE,100×magnification, scale:100µm). Area of PT implant. ( C ) Fifteen days after implantation, Group KC10; moderate inflammatory infiltrate with intense vascularization with CV of various sizes (HE, 400× magnification, scale: 25 µm). ( D ) Fifteen days after implantation, Group KC50: deposition of delicate CFD in parallel bundles, ovoid and fusiform YF, and light inflammatory infiltrate (LII) (HE, 100× magnification, scale:100 µm). Area of PT implant. HE, hematoxylin and eosin.